Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Microsampling Approach for Personalized Monitoring of Kinase Inhibitor Targeted Therapies

NCT05598788 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT05598788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05598788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Microsampling Approach for Personalized Monitoring of Kinase Inhibitor Targeted Therapies
Lead sponsor
Rennes University Hospital
Phase
Observational
Overall status
Completed
Start date
March 3, 2023
Completion date
April 24, 2025
Enrollment
160 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

blood concentrations of nine anti-cancer drugs : axitinib, olaparib, regorafénib, cabozantinib, niraparib, talazoparib, palbociclib, abemaciclib, tucatinib